{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:43Z","timestamp":1786649683827,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>There are no published case reports of esomeprazole-induced photoallergic dermatitis. We report here a 58-year-old lady with prior history of propylthiouracil and carbimazole-induced photoallergy, who presented with heartburn and dysphagia. She was diagnosed to have erosive esophagitis and was treated with esomeprazole, following which she developed photoallergic dermatitis. It improved on cessation of the drug and did not recur on subsequent treatment with ranitidine. Naranjo score for this adverse drug event was 8, thereby making it a probable adverse drug reaction. This reaction may be due to sulphur moiety, which is common to all these drugs. Physicians must be aware of this possible side-effect, especially in patients with prior history of photoallergy to other drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0022-3859.68648","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T06:08:48Z","timestamp":1282543728000},"page":"229-231","source":"Crossref","is-referenced-by-count":11,"title":["Esomeprazole-induced photoallergic dermatitis"],"prefix":"10.4103","volume":"56","author":[{"given":"A","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Gogtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Khopkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20240205","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/00365520310002797","article-title":"Adverse reactions to pantoprazole","volume":"38","author":"Ricciardi","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"R3-20-20240205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2340\/00015555-0335","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors","volume":"88","author":"Dam","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"R4-20-20240205","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of esophagitis: Clinical and functional correlates and further validation of Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"R5-20-20240205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20-20240205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.2610100102","article-title":"Omeprazole, the first proton pump inhibitor","volume":"10","author":"Lindbergh","year":"1990","journal-title":"Med Res Rev"},{"key":"R7-20-20240205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/290159a0","article-title":"Substituted benzimidazole inhibit gastric acid secretion by blocking (H+ + K+ ) ATPase","volume":"290","author":"Fellenius","year":"1981","journal-title":"Nature"},{"key":"R8-20-20240205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrd1010","article-title":"A 0 proton -0 pump inhibitor expedition : The case histories of omeprazole and esomeprazole","volume":"2","author":"Olbe","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R9-20-20240205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Journal of Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005257-201056030-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:59Z","timestamp":1786647419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005257-201056030-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.4103\/0022-3859.68648","relation":{},"ISSN":["0022-3859"],"issn-type":[{"value":"0022-3859","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}